Figures & data
Figure 1. Bone marrow aspirate from the acquired amegakaryocytic thrombocytopenic purpura patient at the time of diagnosis (December 2004) and during treatment with romiplostim (February 2013). (A, D): Smear, May-Giemsa stain, ×400; (B, E): Clot section, HE stain, ×100; (C, F): Clot section, Silver stain, ×100.
Figure 2. The platelet counts in the acquired amegakaryocytic thrombocytopenic purpura patient prior to and following treatment with romiplostim. Each arrow denotes a transfusion of 20 units of platelet concentrate.
